Eli Lilly’s New “Triple G” Drug Retatrutide Crushes Trial
Eli Lilly announced astonishing weight loss results for the GLP-1 drug retatrutide among people with eating addiction.
New Study Uses GLP-1 Drugs to Map the Pathways of Addiction
A summary of the research on GLP-1 drugs and addiction brings us one step closer to a unified theory of addiction.
Are GLP-1 Drugs the Solution to Eating Addiction?
If you’re using GLP-1 drugs to lose weight, you’re only getting half the story.
The Latest Research on GLP-1 Drugs and Addiction
Dr. Caroline L. Haass-Koffler at the Clinical Neuroscience Lab at Brown University discusses the impact of GLP-1 drugs on addiction research.
New in Concierge Medicine: GLP-1 Drugs for Addiction Treatment
Caron Treatment Centers report excellent results using GLP-1 drugs to treat a variety of addictions.
The Latest Research on Using GLP-1 Drugs to Battle Addiction
GLP-1 drugs in the treatment of addiction was a theme at the 56th annual conference of the American Society of Addiction Medicine (ASAM).